Our products are marketed to patients, pharmacies and physicians. The marketing mix and target groups differ between countries, depending on the degree to which patients individually make decisions about their treatment
We collaborate with pharmaceutical companies covering more than 40 countries with a total of 2 billion inhabitants. Our most significant markets are currently in South East Asia, North Africa and the Middle East countries, as well as Central America